Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Weight Loss Clinic Bangkok — Doctor-Led GLP-1
医生推荐
Medical Weight Loss Hub

Weight Loss Clinic Bangkok — Doctor-Led GLP-1

Feel Better. Live Longer. · Healthi Life, Ekkamai 10 Bangkok

Doctor-led medical weight loss at Healthi Life Ekkamai. Three physician-supervised GLP-1 options — Mounjaro, Wegovy and Retatrutide — selected on the basis of your medical history, contraindications and baseline biomarkers. Prescription only.

起价From ฿10,000

Per vial — full program confirmed at physician consultation

预约咨询WhatsAppCall +66 91 999 1744
Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

您将获得

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Personalized GLP-1 selection and titration plan
为什么选择此疗程

Why a Doctor-Led GLP-1 Program

Doctor-Led, Not Cosmetic

Programs initiated by a licensed physician after full medical intake and contraindication screening.

Three GLP-1 Options

Mounjaro (dual GIP/GLP-1), Wegovy (GLP-1), Retatrutide (investigational triple agonist) — matched to your profile.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

MTC, MEN-2, pancreatitis and pregnancy screening before any prescription.

Injection Training

Weekly subcutaneous self-injection taught in clinic, with adherence support.

Longevity Integration

Integrated with hormone, metabolic and biomarker programs for long-term outcomes.

这适合您吗？

适合人群

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review
  • Expats and international visitors — start in-clinic, continue by telemedicine

不建议人群

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
您的旅程

Our 4-Step Medical Weight Loss Process

1

Physician Consultation

Full medical history, medication review and goal-setting with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before any prescription.

3

Molecule Selection

The physician selects Mounjaro, Wegovy or Retatrutide based on your profile and contraindications.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

医学卓越

为什么信赖 Healthi Life

医生主导的方案、国际认证以及对曼谷客人安全的承诺。

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards

Mounjaro vs Wegovy vs Retatrutide

A factual comparison of mechanism, status and administration. Individual response varies; all three require physician supervision.

FeatureMounjaroWegovyRetatrutide
MoleculeTirzepatideSemaglutideRetatrutide
Receptor targetsGIP + GLP-1 (dual)GLP-1 onlyGIP + GLP-1 + glucagon (triple)
Injection frequencyOnce weeklyOnce weeklyOnce weekly
Regulatory statusFDA approved (T2D, weight)FDA approved (weight)Investigational (Phase III)
ManufacturerEli LillyNovo NordiskEli Lilly
At Healthi LifeFrom ฿12,000 / vialOn requestFrom ฿10,000 / vial

⚕️ Prescription-only medicines. Initiated and supervised by a licensed physician at Healthi Life Ekkamai.

套餐

选择您的方案

Wegovy Program

On request

  • Semaglutide 2.4 mg weekly
  • Physician consultation
  • Biomarker review
  • Injection training
选择套餐
推荐

Mounjaro Program

From ฿12,000

  • Tirzepatide 2.5–10 mg weekly
  • Physician consultation
  • Biomarker review
  • Injection training
选择套餐

Retatrutide Program

From ฿10,000

  • Investigational triple agonist
  • Research-use informed consent
  • Extended biomarker panel
  • Monthly follow-up
选择套餐
常见问题

常见问题解答

A physician-supervised program combining medical intake, contraindication screening, baseline biomarkers, a prescribed GLP-1 medication (Mounjaro, Wegovy or Retatrutide) and monthly follow-up. It is doctor-led, not a cosmetic or over-the-counter service.

There is no single best option. Mounjaro is a dual GIP/GLP-1 agonist approved for type 2 diabetes and weight management. Wegovy is a GLP-1 agonist approved for weight management. Retatrutide is investigational. The physician selects based on indications, contraindications and biomarker profile.

No. Retatrutide is an investigational triple agonist (Phase III) and is not authorised in the European Union, so it is neither sold nor prescribed in European pharmacies. At Healthi Life Ekkamai in Bangkok it is administered only under physician supervision in a research framework, with informed consent, from ฿10,000 per vial. Products sold online without a prescription carry no quality guarantee and are never recommended.

Mounjaro and Wegovy are prescription medicines and must be initiated by a licensed physician. Retatrutide is investigational and is offered only under physician supervision in a research framework. They cannot be sold over the counter.

Most guests follow a 3 to 12 month physician-supervised program, with monthly follow-up. Duration is individualized based on clinical goals, tolerability, biomarker trends and the broader longevity plan.

The most reported effects are nausea, diarrhea, decreased appetite, vomiting and constipation, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease. Every program includes monthly side-effect review.

Yes. HbA1c, lipid panel, hepatic and renal function are established before the first dose. For Retatrutide, an extended panel is added. Follow-up labs are reviewed at every monthly visit.

Yes. GLP-1 medicines such as Mounjaro and Wegovy are legal in Thailand when prescribed by a licensed physician, with no residency or long-term visa required. Expats and short-stay visitors are equally welcome at Healthi Life Ekkamai — your program starts with an in-clinic physician consultation and baseline labs, and monthly follow-up can continue by telemedicine once you have travelled home, so dosing stays monitored.

GLP-1 medicines are temperature-sensitive and must be kept cold. After in-clinic injection training, your physician advises on safe cold-chain transport, self-injection and titration for the weeks between visits. Retatrutide, being investigational, is administered within a supervised research framework and is not dispensed for unsupervised long-term travel.

研究结果说明了什么

以 GIP/GLP-1 受体激动剂进行的医学体重管理，建立在 3 期随机安慰剂对照试验之上。以下是这些研究结果，并列出每项研究的实测数据。

  1. 在一项为期 72 周、纳入 2539 名成人的随机安慰剂对照试验中，体重平均变化在 5 毫克组为 −16.0%，10 毫克组为 −21.4%，15 毫克组为 −22.5%，安慰剂组为 −2.4%。

    Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine, 2022

  2. 随访至 176 周，接受治疗的肥胖合并糖尿病前期的受试者中有 1.3% 进展为 2 型糖尿病，安慰剂组为 13.3%（风险比 0.07，P < 0.001）。15 毫克组体重平均变化为 −19.7%，安慰剂组为 −1.3%。

    Tirzepatide for Obesity Treatment and Diabetes PreventionNew England Journal of Medicine, 2024

  3. 一项更新的系统评价与荟萃分析汇总了每周一次替尔泊肽与安慰剂的对照试验（含 SURMOUNT-2），确认了合并人群中的体重管理效果。

    Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: an updated systematic review and meta-analysis including the latest SURMOUNT-2 trialSystematic review and meta-analysis, 2024

这些研究描述的是其各自试验人群中观察到的结果，不能用于预测您的治疗效果，也不构成任何疗效保证。Healthi Life 的干细胞治疗须经医生面诊和个体医学评估后方可进行。

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

本页仅供一般信息参考，不构成医疗建议、诊断或治疗。个体结果存在差异。 ⁨Mounjaro, Wegovy — tirzepatide, semaglutide⁩为处方药，须经执业医师评估后方可开具与使用。本页面提供医学信息，并非广告或诊疗要约。 请务必就您的健康状况咨询合格医生。请参阅我们的 完整医疗免责声明.

Book a Medical Weight Loss Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and the GLP-1 molecule best suited to your profile.

位置

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

营业时间

Mon-Sat: 11:00 AM – 7:00 PM

响应时间：2小时内

预约咨询通过WhatsApp联系我们+66 91 999 1744

相关服务

了解其他可与您的健康计划相配合的疗程

Recovery & Performance

All recovery & performance treatments

了解更多

Peptide Therapy

Physician-led peptide programs

了解更多

Wegovy Bangkok

Semaglutide GLP-1 program

了解更多

Ozempic Bangkok

Semaglutide (Ozempic) GLP-1 care

了解更多

Retatrutide Bangkok

Investigational triple agonist

了解更多

Mounjaro Bangkok

Tirzepatide dual GIP/GLP-1 program

了解更多